New FDA-approved sunscreen ingredient promises stronger UVA protection without the white cast

Americans may soon have a new option for protecting their skin from the sun after the Food and Drug Administration approved a new sunscreen ingredient for the first time in more than two decades.

The FDA recently cleared bemotrizinol, a UV filter that has been widely used in countries including Australia, parts of Europe, South Korea, and China for years. The approval marks the first time since 1999 that the agency has approved a new sunscreen filter in the United States.

Dermatologists say the move could expand sunscreen choices and help people find products that provide stronger protection while feeling more comfortable on the skin.

“The addition of bemotrizinol to sunscreens in the United States is extremely exciting because it will give us better tools to protect the skin,” dermatologist Joshua Zeichner told Health.

What is bemotrizinol?

Bemotrizinol is a chemical sunscreen filter designed to absorb ultraviolet radiation before it can damage the skin.

The ingredient provides broad-spectrum protection, meaning it helps block both UVA and UVB rays.

UVB rays are mainly responsible for sunburn, while UVA rays penetrate deeper into the skin and contribute to premature aging and skin cancer risk.

The ingredient’s manufacturer, DSM Nutritional Products, submitted the proposal for U.S. approval in 2024. The FDA determined that bemotrizinol is generally recognized as safe and effective for use in sunscreen products for adults and children over six months old.

How is it different from current sunscreens?

Experts say bemotrizinol has several advantages compared with many sunscreen filters currently available in the U.S.

One major benefit is its ability to provide strong UVA protection, which experts say many existing American sunscreens may not deliver as effectively as consumers expect.

The ingredient also offers cosmetic benefits. Unlike some mineral sunscreens containing zinc oxide or titanium dioxide that can leave a visible white residue, bemotrizinol dries clear and spreads easily across the skin.

Zeichner noted that the ingredient may be especially appealing for people who want sunscreen that feels lightweight and blends naturally.

Another advantage is that bemotrizinol remains stable when exposed to sunlight, meaning it does not break down as quickly as some other chemical filters.

Dermatologists also say the ingredient’s comfortable texture could encourage more people to use sunscreen consistently.

Deborah S. Sarnoff said people are more likely to use sun protection regularly when products match their personal preferences and needs.

When will bemotrizinol sunscreens be available?

Sunscreens containing bemotrizinol are not yet available in U.S. stores.

Manufacturers will be able to begin adding the ingredient to products starting August 9, 2026, with dermatologists expecting products to appear on shelves later in the summer or early fall.

The ingredient will initially be sold under the brand name PARSOL Shield.

Should people switch to bemotrizinol sunscreens?

Dermatologists say the choice will depend on individual preferences.

People who prefer mineral sunscreens may continue using options containing zinc oxide or titanium dioxide. However, experts say those who are comfortable with chemical sunscreens may benefit from products containing bemotrizinol because of its broad-spectrum protection and lightweight feel.

The ingredient may also appeal to people with deeper skin tones who want to avoid the white cast sometimes left behind by traditional mineral formulas.

Dermatologist Farah Moustafa said many patients have already searched for bemotrizinol sunscreens while traveling overseas and are excited that the ingredient will soon be available in the U.S.

Experts say the approval represents a major step forward in sunscreen options, giving consumers more choices for protecting their skin from harmful UV exposure.